Skip to navigation

ASTON/TAMRO Small Cap Fund

CUSIP 00078H21600078H141
Share Class Inception 11/30/20001/4/2005
Gross Exp Ratio (%) 1.311.06
Net Exp Ratio (%) 1.311.06
NAV Change (%) 0.00 0.00
Dividend Frequency Annual
Benchmark Russell 2000 Index
Morningstar Category Small Growth

Overall Morningstar Rating

ASTON/TAMRO Small Cap  Shares received a Morningstar rating.

Among 672 Small Growth funds derived from a weighted average of the Fund’s 3-, 5- and 10-year risk-adjusted returns as of 5/31/15.

Portfolio Managers

Philip D.  Tasho, CFA
Philip D. Tasho, CFA

Philip D. Tasho, CFA

Philip D.  Tasho, CFA

Mr. Tasho is the Chief Executive Officer and Chief Investment Officer of TAMRO Capital Partners, and a co-founder of the firm. He is the architect of TAMRO's investment philosophy and process, and has been responsible for the day-to-day management of the Fund since its November 2000 inception. He began his investment management career as a Trust Investment Officer for First American Bank in 1980, and has been recognized by the national media on such programs as Wall $treet Week with Louis Rukeyser, CNBC's Power Lunch, Nightly Business Report, and Bloomberg News. Mr. Tasho earned a BA from Grinnell College, an MBA in Finance and Investments from George Washington University, and holds the Chartered Financial Analyst designation.

Timothy A.  Holland, CFA
Timothy A. Holland, CFA

Timothy A. Holland, CFA

Timothy A.  Holland, CFA

Mr. Holland is a partner and portfolio manager at TAMRO Capital Partners, covering companies within the Financials sector, and has been a Co-Portfolio Manager on the Fund since February 2010. He joined TAMRO in April 2005 following nearly five years with Manley Asset Management LP. He earned his BA from Drew University and holds the Chartered Financial Analyst designation.

Investment Strategy

The ASTON/TAMRO Small Cap Fund focuses on bottom-up stock selection with the goal of identifying companies that possess a sustainable competitive advantage combined with an attractive valuation.


The Fund seeks to provide long-term capital appreciation.

Risk Considerations

Small- and mid-cap stocks are considered riskier than large-cap stocks due to greater potential volatility and less liquidity.

Fund Stats (as of 3/31/15) N SharesI Shares
Origin Of Information FactSetFactSet
Sales Load NoneNone
Total Net Assets (7/3/15)$0.00$0.00
Turnover 70%70%
Minimum Investment 2,5001,000,000
Alpha (3 yr.) N/AN/A
Beta (3 yr.) N/AN/A
R-Squared (3 yr.) N/AN/A
Standard Dev (3 yr.) N/AN/A
Sharpe Ratio (3 yr.) N/AN/A
Current Wtd Average P/E (trailing) 25.6125.61
Current Wtd Average P/B (trailing) 3.423.42
Median Mkt Cap ($Mil) 2,1322,132
Average Wtd Coupon N/AN/A
Effective Maturity N/AN/A
Sector Breakdown (as of 3/31/2015)
Consumer Discretionary
Information Technology
Health Care
Consumer Staples
Cash Equivalents & Other
Top 10 Holdings (as of 3/31/2015)
CompanyTickerCUSIPNumber of SharesMarket Value% of Net Assets
BANK OF THE OZARKS INC OZRK 63904106 553,111 $20,426,389.23 2.78%
NU SKIN ENTERPRISES INC NUS 67018T105 322,718 $19,430,850.78 2.64%
DEXCOM INC DXCM 252131107 297,620 $18,553,630.80 2.52%
COLONY FINANCIAL INC CLNY 19624R106 691,252 $17,917,251.84 2.44%
ICONIX BRAND GROUP INC ICON 451055107 532,095 $17,915,638.65 2.44%
ADVISORY BOARD CO/THE ABCO 00762W107 333,086 $17,746,822.08 2.41%
BOFI HOLDING INC BOFI 05566U108 189,398 $17,621,589.92 2.40%
ICU MEDICAL INC ICUI 44930G107 187,775 $17,489,363.50 2.38%
GEO GROUP INC/THE GEO 36162J106 376,480 $16,467,235.20 2.24%
CEPHEID CPHD 15670R107 288,468 $16,413,829.20 2.23%
Past performance does not guarantee future results. Investment return and principal value of mutual funds will vary with market conditions, so that shares, when redeemed, may be worth more or less than their original cost.

As the fund is actively managed, the securities as presented may not represent the current or future composition of the portfolio.

Designed and created by DDM Marketing & Communications.